Intel and DigitalBridge launch GenAI software platform, Articul8

An outline of a human brain but detailed with circuit board-styling | Articul8

Intel and global investment firm, DigitalBridge Group, have launched Articul8 AI, an independent company which offers users a full-stack, vertically-optimized and secure GenAI software platform.

The platform delivers AI capabilities that keep customer data, training and inference within the enterprise security perimeter. In addition, the platform offers customers the choice of cloud, on-premises or hybrid deployment.

Articul8 was created with intellectual property and technology developed at Intel, and both Intel and DigitalBridge plan to remain aligned on go-to-market opportunities and to collaborate on driving GenAI adoption in the enterprise.

Arun Subramaniyan, formerly vice president and general manager in Intel’s data center and AI group, has assumed leadership of Articul8 as its CEO.

The initiative of DigitalBridge, DigitalBridge Ventures, served as the lead investor of Articul8. Intel, along with a syndicate of established venture investors, including Fin Capital, Mindset Ventures, Communitas Capital, GiantLeap Capital, GS Futures and Zain Group, has taken an equity stake in the company.

Pat Gelsinger, CEO of Intel, said: “With its deep AI and HPC domain knowledge and enterprise-grade GenAI deployments, Articul8 is well positioned to deliver tangible business outcomes for Intel and our broader ecosystem of customers and partners. As Intel accelerates AI everywhere, we look forward to our continued collaboration with Articul8.”

Marc Ganzi, CEO of DigitalBridge, said: “Every global enterprise today is challenged to integrate GenAI capabilities into its workflows. Articul8 has built a scalable and easy-to-deploy GenAI software platform that is already enabling enterprises to unlock value from their proprietary data. We see GenAI as a pivotal force driving digital infrastructure, and we are pleased to collaborate with Intel to support Articul8’s growth.”

Rich Lesser, global chair of BCG, said: “GenAI is at the forefront of our clients’ business strategy and needs. Our collaboration began nearly two years ago while the venture was still in the incubation stage at Intel. Since then, we have deployed Articul8 products for multiple clients seeking production-ready platforms with rapid time to market.”